Provided by Tiger Fintech (Singapore) Pte. Ltd.

Merck

85.70
-0.2900-0.34%
Post-market: 85.750.0490+0.06%19:59 EDT
Volume:6.55M
Turnover:561.69M
Market Cap:214.06B
PE:13.21
High:86.46
Open:85.66
Low:85.24
Close:85.99
52wk High:111.58
52wk Low:73.31
Shares:2.50B
Float Shares:2.49B
Volume Ratio:0.62
T/O Rate:0.26%
Dividend:3.16
Dividend Rate:3.69%
EPS(TTM):6.49
EPS(LYR):6.76
ROE:35.42%
ROA:13.01%
PB:4.37
PE(LYR):12.68

Loading ...

Press Release: Shareholders of Verona Pharma Approve Proposed Acquisition by Merck

Dow Jones
·
Sep 25

Halozyme price target raised to $90 from $75 at Benchmark

TIPRANKS
·
Sep 24

Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?

Motley Fool
·
Sep 24

3 Dividend Stocks Perfect for Millennial Investors

Motley Fool
·
Sep 24

Eli Lilly's boss calls UK the 'worst' European country for drug prices

Reuters
·
Sep 24

IO Biotech Announces Late-Breaking Abstract in Advanced Melanoma Selected for Oral Presentation at ESMO Congress 2025

GlobeNewswire
·
Sep 23

Variational AI: Enters Collaboration With Merck to Apply Generative AI to Drug Discovery

THOMSON REUTERS
·
Sep 23

Variational AI: Under Agreement, Co to Receive Upfront Payment With Total Potential Deal Value of up to $349 Mln

THOMSON REUTERS
·
Sep 23

Multinational Pharma Companies Bet Big on Ab-LNP, BioLegend Captures New Opportunities in Nucleic Acid Drug Delivery

Deep News
·
Sep 23

Kelun-Biotech to Present Results from Multiple Clinical Studies at the 2025 ESMO Congress

prnewswire
·
Sep 23

Merck KGaA And Siemens Extend Partnership

Reuters
·
Sep 23

Merck & Co. Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Sep 23

3 Dirt-Cheap Stocks to Buy Right Now

Motley Fool
·
Sep 22

Merck Says US FDA Approves Keytruda Qlex Subcutaneous Injection

MT Newswires Live
·
Sep 22

BioCity: From "Antibody Supermarket" to Global Partnership Hub, Dual Business Lines Gaining Momentum

Deep News
·
Sep 22

Biocytogen's "Dual Business Lines" Continue Scaling: Multiple International Collaborations Enter New Phase

Deep News
·
Sep 22

Kroger, Merck, Workday, AbbVie, Eli Lilly: Trending by Analysts

TIPRANKS
·
Sep 20

What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill

Motley Fool
·
Sep 20

FDA Approves Merck’s Keytruda Qlex™ (Pembrolizumab and Berahyaluronidase Alfa-Pmph) Injection for Subcutaneous Use in Adults Across Most Solid Tumor Indications for Keytruda® (Pembrolizumab)

THOMSON REUTERS
·
Sep 20

Merck & Co Inc - Expects Keytruda Qlex Available in U.S. Late September

THOMSON REUTERS
·
Sep 20